These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22150004)

  • 1. Immunotherapy against invasive mold infections.
    Antachopoulos C; Katragkou A; Roilides E
    Immunotherapy; 2012 Jan; 4(1):107-20. PubMed ID: 22150004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of infections caused by rare filamentous fungi.
    Katragkou A; Roilides E
    Clin Microbiol Infect; 2012 Feb; 18(2):134-9. PubMed ID: 22044625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy against invasive fungal diseases in stem cell transplant recipients.
    Lehrnbecher T; Tramsen L; Koehl U; Schmidt S; Bochennek K; Klingebiel T
    Immunol Invest; 2011; 40(7-8):839-52. PubMed ID: 21627412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spanish Paediatric Infectious Diseases Society consensus document on the treatment of fungal infections based on the immune response].
    Martín A; Soler-Palacín P; Español T; Dapena JL; Urrutia E; Navarro M; Alvez F; Figueras C;
    An Pediatr (Barc); 2010 Dec; 73(6):362.e1-8. PubMed ID: 20638349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines and fungal infections.
    Antachopoulos C; Roilides E
    Br J Haematol; 2005 Jun; 129(5):583-96. PubMed ID: 15916680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal immunotherapy and immunomodulation: a double-hitter approach to deal with invasive fungal infections.
    Hamad M
    Scand J Immunol; 2008 Jun; 67(6):533-43. PubMed ID: 18397201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICU-acquired immunosuppression and the risk for secondary fungal infections.
    Monneret G; Venet F; Kullberg BJ; Netea MG
    Med Mycol; 2011 Apr; 49 Suppl 1():S17-23. PubMed ID: 20718607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate and adaptive antifungal immune responses: partners on an equal footing.
    Hamad M
    Mycoses; 2012 May; 55(3):205-17. PubMed ID: 21815944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune response to fungal infections.
    Shoham S; Levitz SM
    Br J Haematol; 2005 Jun; 129(5):569-82. PubMed ID: 15916679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal immunity and adjuvant cytokine immune enhancement in cancer patients with invasive fungal infections.
    Safdar A
    Clin Microbiol Infect; 2007 Jan; 13(1):1-4. PubMed ID: 17184281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of immunoreconstitution in the management of refractory opportunistic fungal infections.
    Roilides E; Dignani MC; Anaissie EJ; Rex JH
    Med Mycol; 1998; 36 Suppl 1():12-25. PubMed ID: 9988488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients.
    Leen AM; Myers GD; Bollard CM; Huls MH; Sili U; Gee AP; Heslop HE; Rooney CM
    Ann N Y Acad Sci; 2005 Dec; 1062():104-15. PubMed ID: 16461793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for invasive fungal infections: from bench to bedside.
    Pappas PG
    Drug Resist Updat; 2004 Feb; 7(1):3-10. PubMed ID: 15072766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ-specific mechanisms linking innate and adaptive antifungal immunity.
    Drummond RA; Lionakis MS
    Semin Cell Dev Biol; 2019 May; 89():78-90. PubMed ID: 29366628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines and mycoses.
    Stevens DA; Walsh TJ; Bistoni F; Cenci E; Clemons KV; Del Sero G; Fè d'Ostiani C; Kullberg BJ; Mencacci A; Roilides E; Romani L
    Med Mycol; 1998; 36 Suppl 1():174-82. PubMed ID: 9988506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fish immunity and parasite infections: from innate immunity to immunoprophylactic prospects.
    Alvarez-Pellitero P
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):171-98. PubMed ID: 18783835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive immune therapy for fungal infections.
    Casadevall A; Pirofski LA
    Clin Infect Dis; 2001 Oct; 33(7):1048-56. PubMed ID: 11528579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive antifungal T cell immunotherapy--into the clinic?
    Lehrnbecher T; Schmidt S; Koehl U; Schuster FR; Uharek L; Klingebiel T; Tramsen L
    Med Mycol; 2011 Apr; 49 Suppl 1():S164-9. PubMed ID: 20586680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of efficacy trials of cytokines in combination with antifungal drugs.
    Kullberg BJ; Oude Lashof AM; Netea MG
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S218-23. PubMed ID: 15546121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive immunotherapy with virus-specific T cells.
    Fuji S; Kapp M; Grigoleit GU; Einsele H
    Best Pract Res Clin Haematol; 2011 Sep; 24(3):413-9. PubMed ID: 21925094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.